BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2804809
Number of visits today
846
Number of downloads
2057907
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Hoffmann MJ, Schulz WA. Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma. Cancers (Basel) 2021;13:6040. [PMID: 34885146 DOI: 10.3390/cancers13236040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Galiniak S, Mołoń M, Biesiadecki M, Mokrzyńska A, Balawender K. Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer. Antioxidants (Basel) 2023;12. [PMID: 36829836 DOI: 10.3390/antiox12020277] [Reference Citation Analysis]
2 Schulz WA. Bladder Cancer. Molecular Biology of Human Cancers 2023. [DOI: 10.1007/978-3-031-16286-2_14] [Reference Citation Analysis]
3 Huang EY, Chen YK, Ou CP, Chen YT, Chen SF, Huang WJ, Liang KH. Oncogenic Roles of Polycomb Repressive Complex 2 in Bladder Cancer and Upper Tract Urothelial Carcinoma. Biomedicines 2022;10. [PMID: 36428492 DOI: 10.3390/biomedicines10112925] [Reference Citation Analysis]
4 Dhawan D, Ramos-vara JA, Utturkar SM, Ruple A, Tersey SA, Nelson JB, Cooper B, Heng HG, Ostrander EA, Parker HG, Hahn NM, Adams LG, Fulkerson CM, Childress MO, Bonney P, Royce C, Fourez LM, Enstrom AW, Ambrosius LA, Knapp DW. Identification of a naturally-occurring canine model for early detection and intervention research in high grade urothelial carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1011969] [Reference Citation Analysis]
5 Akman B, Erkek-ozhan S. Implications of Chromatin Modifier Mutations in Epigenetic Regulation of Bladder Cancer. Urologic Cancers 2022. [DOI: 10.36255/exon-publications-urologic-cancers-bladder-cancer-epigenetics] [Reference Citation Analysis]
6 Meghani K, Folgosa Cooley L, Piunti A, Meeks JJ. Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer. Bladder Cancer 2022;8:101-12. [PMID: 35898580 DOI: 10.3233/BLC-211609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Thomas J, Sonpavde G. Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer. Cancers 2022;14:1795. [DOI: 10.3390/cancers14071795] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345